review

Trump responds after Facebook ban extended pending additional review

Former President Donald Trump will remain banned on Facebook for now, the Facebook Oversight Board announced Wednesday, adding that Facebook must review the matter...
Ketelo Backar
2 min read

U.S. prosecutors want ‘special master’ to review Giuliani evidence

By Jan Wolfe and Karen Freifeld WASHINGTON (Reuters) – U.S. prosecutors on Tuesday asked a judge to create a process for reviewing evidence seized...
Ketelo Backar
1 min read

EU regulator begins real-time review of first Chinese COVID-19…

EU regulator begins real-time review of first Chinese COVID-19 vaccine
Ketelo Backar
2 sec read

White House completes North Korea policy review

The Biden administration said Friday it has completed a review of U.S. policy toward North Korea and suggested it has limited hopes of brokering...
Ketelo Backar
1 min read

EMA starts review of GSK’s monoclonal antibody to treat…

By Reuters Staff (Reuters) – The European Medicines Agency said on Thursday it is reviewing available data on the use of GlaxoSmithKline’s monoclonal antibody...
Ketelo Backar
1 min read

Mexico reports 2,192 new coronavirus deaths after data review

MEXICO CITY (Reuters) -Mexico’s government on Saturday reported 2,192 new confirmed coronavirus deaths, one of its biggest one-day tolls during the pandemic, after consolidating...
Ketelo Backar
45 sec read

India to review COVID-19 vaccines after blood clot warning

(Reuters) – A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of...
Ketelo Backar
46 sec read

Australia to continue AstraZeneca vaccine rollout, review EU findings

By Renju Jose SYDNEY (Reuters) -Australia has no current plans to change the rollout of the AstraZeneca COVID-19 vaccine, Prime Minister Scott Morrison said...
Ketelo Backar
1 min read

U.S. FDA extends review of Pfizer’s experimental skin disease…

(Reuters) – Pfizer Inc said on Wednesday the U.S. Food and Drug Administration (FDA) had extended its review of the company’s experimental treatment for...
Ketelo Backar
35 sec read